2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL1825527

Nc1nc(N)c2nc[nH]c2n1.Nc1nc2[nH]cnc2c(=O)[nH]1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
GLA P06280 1/20 0.50
PMP22 Q01453 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PNP P00491 3/20 0.44
DYRK1A Q13627 1/20 0.41
PDPK1 O15530 1/20 0.37
GDA Q9Y2T3 1/20 0.37
MAPT P10636 1/20 0.37
TP53 P04637 2/20 0.36
HBB P68871 2/20 0.36
MITF O75030 1/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
HIF1A Q16665 1/20 0.36
AKR1B1 P15121 1/20 0.35
XDH P47989 2/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL5259 0.89 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL4658042 0.89 ALDH1A1 (0.61) ALDH1A1KDM4ELMNAGLAPMP22
2,6-Diaminopurine SCHEMBL6755672 0.88 KDM4E (0.40) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL28373862 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL21611717 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL9512016 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL4063556 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL2895087 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL865492 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22
Guanine SCHEMBL28191009 0.87 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAGLAPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688778-A VIRICIDES INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 1997-11-18 US claimed
EP-0968223-B1 BIOCONJUGATION OF MACROMOLECULES SIGMA ALDRICH CO LLC (US) 2016-12-21 EP disclosed
EP-2256133-B1 Bioconjugation of macromolecules SIGMA ALDRICH CO LLC (US) 2016-12-14 EP disclosed
EP-2319854-B1 Bioconjugation Of Macromolecules SIGMA ALDRICH CO LLC (US) 2016-11-30 EP disclosed
EP-2319855-B1 Bioconjugation of Macromolecules SIGMA ALDRICH CO LLC (US) 2016-04-06 EP disclosed
EP-2319854-A1 Bioconjugation Of Macromolecules Sigma-Aldrich Co. (US) 2011-05-11 EP disclosed
EP-2319855-A1 Bioconjugation of Macromolecules Sigma-Aldrich Co. (US) 2011-05-11 EP disclosed
EP-2256133-A1 Bioconjugation of macromolecules Sigma-Aldrich Co. (US) 2010-12-01 EP disclosed
US-20040116685-A1 Method for solution phase synthesis of oligonucleotides PROLIGO LLC 2004-06-17 US disclosed
US-6737236-B1 DERIVATIZING OLIGONUCLEOTIDES AND PROTEINS USING CYCLOADDITION REACTIONS INCLUDING DIELS-ALDER REACTION OR 1,3-DIPOLAR CYCLOADDITION REACTIONS PROLIGO, LLC 2004-05-18 US disclosed
US-6001966-A REACTING N-TERMINAL PROTECTED AMINO ACID WITH PEPTIDE STARTING MATERIAL FORMING A PEPTIDE PRODUCT, PARTITIONING FROM UNREACTED MATERIAL AND REAGENTS BASED ON PRESENCE OF N-TERMINAL BLOCKING/ANCHORING GROUP PROLIGO LLC (US) 1999-12-14 US disclosed
US-5874532-A USING A N-TERMINAL PROTECTED AMINO ACID MONOMER NEXSTAR PHARMACEUTICALS, INC. (US) 1999-02-23 US disclosed
EP-0767657-A4 NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT NEXSTAR PHARMACEUTICALS INC (US) 1999-01-20 EP disclosed
WO-1998047910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO LLC (US) 1998-10-29 WO disclosed
EP-0863910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 1998-09-16 EP disclosed
WO-1998030575-A1 BIOCONJUGATION OF MACROMOLECULES PROLIGO LLC (US) 1998-07-16 WO disclosed
WO-1998030578-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES PROLIGO LLC (US) 1998-07-16 WO disclosed
WO-1997014706-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NEXSTAR PHARMACEUTICALS, INC. (US) 1997-04-24 WO disclosed
EP-0767657-A1 NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT NeXstar Pharmaceuticals, Inc. (US) 1997-04-16 EP disclosed
WO-1995035102-A1 NOVEL METHOD OF PREPARATION OF KNOWN AND NOVEL 2'-MODIFIED NUCLEOSIDES BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT NEXSTAR PHARMACEUTICALS, INC. (US) 1995-12-28 WO disclosed